These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32905365)

  • 1. Analysis of Patterns of Adverse Transfusion Reactions and Management: A Novel Initiative toward Hemovigilance in a Teaching Hospital of South India.
    Krishnamurthy AV; Mathialagan J; Raghavan ATMV; Srinivasan S
    J Lab Physicians; 2020 Aug; 12(2):133-140. PubMed ID: 32905365
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.
    Sharma DK; Datta S; Gupta A
    Indian J Pharmacol; 2015; 47(4):370-4. PubMed ID: 26285707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-related adverse reactions: From institutional hemovigilance effort to National Hemovigilance program.
    Vasudev R; Sawhney V; Dogra M; Raina TR
    Asian J Transfus Sci; 2016; 10(1):31-6. PubMed ID: 27011667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Adverse Transfusion Reactions in a Tertiary Care Centre of North India: A Step Towards Hemovigilance.
    Bassi R; Aggarwal S; Bhardwaj K; Thakur KK
    Indian J Hematol Blood Transfus; 2017 Jun; 33(2):248-253. PubMed ID: 28596659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Analysis of 7 Years Adverse Transfusion Reaction: A Retrospective Analysis.
    Saha S; Krishna D; Prasath R; Sachan D
    Indian J Hematol Blood Transfus; 2020 Jan; 36(1):149-155. PubMed ID: 32158098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Transfusion Related Adverse Reactions in a Tertiary Care Centre in Bangalore: A 4-Year Hemovigilance Initiative.
    Pai S
    Indian J Hematol Blood Transfus; 2020 Oct; 36(4):733-739. PubMed ID: 33100718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: A preliminary step towards hemovigilance.
    Kumar P; Thapliyal R; Coshic P; Chatterjee K
    Asian J Transfus Sci; 2013 Jul; 7(2):109-15. PubMed ID: 24014939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and implementation of a hemovigilance program at a university veterinary teaching hospital.
    Haines JM; Ngwenyama TR; Martin LG; Wardrop KJ
    J Vet Emerg Crit Care (San Antonio); 2022 May; 32(3):315-321. PubMed ID: 35001463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of buffy coat reduction on the severity of febrile nonhemolytic transfusion reactions with red cell components.
    Singh L; Prinja N; Jain A; Sharma RR; Marwaha N
    Asian J Transfus Sci; 2023; 17(1):69-73. PubMed ID: 37188007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of mandating a dedicated hemovigilance nurse and objectification of 'imputability' levels. Experience from a hospital-based blood centre in India.
    Dhiman Y; Raturi M; Kala M; Kusum A
    Transfus Clin Biol; 2023 Feb; 30(1):96-102. PubMed ID: 36162622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting adverse transfusion reactions: A retrospective study from tertiary care hospital from New Delhi, India.
    Pahuja S; Puri V; Mahajan G; Gupta P; Jain M
    Asian J Transfus Sci; 2017; 11(1):6-12. PubMed ID: 28316433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related adverse reactions in pediatric and surgical patients at a tertiary care teaching hospital in India.
    Ghataliya KJ; Kapadia JD; Desai MK; Mehariya KM; Rathod GH; Bhatnagar N; Gajjar MD
    Asian J Transfus Sci; 2017; 11(2):180-187. PubMed ID: 28970688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion Reactions in Pediatric Patients: An Analysis of 5 Years of Hemovigilance Data From a National Center for Children's Health in China.
    Guo K; Wang X; Zhang H; Wang M; Song S; Ma S
    Front Pediatr; 2021; 9():660297. PubMed ID: 34123967
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products.
    Oakley FD; Woods M; Arnold S; Young PP
    Transfusion; 2015 Mar; 55(3):563-70. PubMed ID: 25145580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort.
    Bhattacharya P; Marwaha N; Dhawan HK; Roy P; Sharma RR
    Asian J Transfus Sci; 2011 Jul; 5(2):164-70. PubMed ID: 21897598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring and reporting transfusion reactions as a quality indicator - a clinical audit.
    Hussain S; Moiz B; Ausat FA; Khurshid M
    Transfus Apher Sci; 2015 Feb; 52(1):122-7. PubMed ID: 25151095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Incidence Rate of Acute Transfusion Reactions in Thalassemia Patients Referred to the Shiraz Thalassemia Centre, Shiraz, Iran, Before and After the Establishment of the Hemovigilance System.
    Kasraian L; Karimi MH
    Hemoglobin; 2015; 39(4):274-80. PubMed ID: 26036919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
    Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Analysis of Transfusion Reactions at a Tertiary Care Center: An Institutional Hemovigilance Study.
    Korkmaz E; Korkut S; Akkoyun N
    J Contin Educ Nurs; 2021 Dec; 52(12):581-588. PubMed ID: 34870535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemovigilance: State 2007-2013 Tunis].
    Mahjoub S; Baccouche H; Raissi A; Ben Hamed L; Ben Romdhane N
    Transfus Clin Biol; 2017 Feb; 24(1):15-22. PubMed ID: 27955922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.